HIF1A and neoplasm: HIF-1α overexpression in tumor tissues is frequently associated with poor prognosis, implying that HIF-1α may have utility as a biomarker for assessing tumor treatment efficacy and prognosis, as well as a possible therapeutic target [19,20].